Free Trial

Pacer Advisors Inc. Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Pacer Advisors Inc. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 73,275 shares of the healthcare conglomerate's stock after purchasing an additional 4,295 shares during the quarter. Pacer Advisors Inc.'s holdings in UnitedHealth Group were worth $37,067,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Center For Asset Management LLC boosted its position in shares of UnitedHealth Group by 46.0% in the 4th quarter. Center For Asset Management LLC now owns 609 shares of the healthcare conglomerate's stock worth $308,000 after purchasing an additional 192 shares during the last quarter. Cornerstone Wealth Group LLC increased its holdings in shares of UnitedHealth Group by 1.6% in the fourth quarter. Cornerstone Wealth Group LLC now owns 12,230 shares of the healthcare conglomerate's stock worth $6,187,000 after acquiring an additional 190 shares in the last quarter. KBC Group NV raised its holdings in shares of UnitedHealth Group by 4.1% during the fourth quarter. KBC Group NV now owns 918,316 shares of the healthcare conglomerate's stock worth $464,539,000 after acquiring an additional 35,973 shares during the period. Union Bancaire Privee UBP SA acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $27,233,000. Finally, Capital Asset Advisory Services LLC boosted its stake in shares of UnitedHealth Group by 11.5% during the 4th quarter. Capital Asset Advisory Services LLC now owns 7,343 shares of the healthcare conglomerate's stock worth $3,767,000 after buying an additional 760 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Ratings Changes

Several research firms have recently weighed in on UNH. Barclays lowered their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. UBS Group decreased their price objective on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a report on Wednesday, October 16th. Truist Financial decreased their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Finally, Morgan Stanley cut their target price on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a research report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $629.32.

Check Out Our Latest Research Report on UNH

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm's stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $1.00 during midday trading on Tuesday, reaching $542.52. The company had a trading volume of 3,161,466 shares, compared to its average volume of 4,791,202. The stock has a market cap of $499.28 billion, a P/E ratio of 35.00, a P/E/G ratio of 1.41 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company's 50 day moving average price is $540.11 and its 200 day moving average price is $565.06.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm's quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the business posted $5.83 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines